Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
268
NCT04591184
A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults
Phase: Phase 1/2
Role: Collaborator
Start: Apr 7, 2021
Completion: Dec 6, 2023